BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25922674)

  • 1. Support for patients with celiac disease: A literature review.
    Ludvigsson JF; Card T; Ciclitira PJ; Swift GL; Nasr I; Sanders DS; Ciacci C
    United European Gastroenterol J; 2015 Apr; 3(2):146-59. PubMed ID: 25922674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary management of celiac disease: Revisiting the guidelines.
    Theodoridis X; Grammatikopoulou MG; Petalidou A; Patelida M; Gkiouras K; Klonizakis M; Pittas S; Bogdanos DP
    Nutrition; 2019 Oct; 66():70-77. PubMed ID: 31220686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet adherence and gluten exposure in coeliac disease and self-reported non-coeliac gluten sensitivity.
    Løvik A; Skodje G; Bratlie J; Brottveit M; Lundin KE
    Clin Nutr; 2017 Feb; 36(1):275-280. PubMed ID: 26714791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for celiac disease in the general population and in high-risk groups.
    Ludvigsson JF; Card TR; Kaukinen K; Bai J; Zingone F; Sanders DS; Murray JA
    United European Gastroenterol J; 2015 Apr; 3(2):106-20. PubMed ID: 25922671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.
    Al-Toma A; Volta U; Auricchio R; Castillejo G; Sanders DS; Cellier C; Mulder CJ; Lundin KEA
    United European Gastroenterol J; 2019 Jun; 7(5):583-613. PubMed ID: 31210940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and barriers to adherence to gluten-free diet among adults with celiac disease: a systematic review.
    Abu-Janb N; Jaana M
    J Hum Nutr Diet; 2020 Dec; 33(6):786-810. PubMed ID: 32348008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiac disease and non-celiac gluten or wheat sensitivity and health in later life: A review.
    Bathrellou E; Kontogianni MD; Panagiotakos DB
    Maturitas; 2018 Jun; 112():29-33. PubMed ID: 29704914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiac disease and COVID-19 in adults: A systematic review.
    Amirian P; Zarpoosh M; Moradi S; Jalili C
    PLoS One; 2023; 18(5):e0285880. PubMed ID: 37192180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance with gluten-free diet in a selected group of celiac children in the Slovak Republic.
    Rimárová K; Dorko E; Diabelková J; Sulinová Z; Makovický P; Baková J; Uhrin T; Jenča A; Jenčová J; Petrášová A; Jenča A; Jenča J
    Cent Eur J Public Health; 2018 Dec; 26 Suppl():S19-S24. PubMed ID: 30817868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Evaluation of Nutritional Status and Problems with Dietary Compliance in Polish Patients with Celiac Disease.
    Kostecka M; Kostecka-Jarecka J; Iłowiecka K; Kostecka J
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twitter Trends for Celiac Disease and the Gluten-Free Diet: Cross-sectional Descriptive Analysis.
    Germone M; Wright CD; Kimmons R; Coburn SS
    JMIR Infodemiology; 2022; 2(2):e37924. PubMed ID: 37113453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and improving adherence to the gluten-free diet in people with coeliac disease.
    Muhammad H; Reeves S; Jeanes YM
    Proc Nutr Soc; 2019 Aug; 78(3):418-425. PubMed ID: 30630540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
    Dretzke J; Edlin R; Round J; Connock M; Hulme C; Czeczot J; Fry-Smith A; McCabe C; Meads C
    Health Technol Assess; 2011 Feb; 15(6):1-244. PubMed ID: 21291629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.